New Delhi, May 31 (IANS) The US Food and Drug Administration (FDA) has flagged serious manufacturing, maintenance and data integrity lapses at a Dabur India manufacturing facility in Dadra and Nagar Haveli, at a time when Indian pharmaceutical and healthcare product makers are facing increased scrutiny from US regulators over quality standards and manufacturing practices.According to the FDA inspection report, the regulator identified multiple deficiencies at the plant, raising concerns over pot…
Latest Dabur India News & Updates
New Delhi, May 7 (IANS) Homegrown FMCG major Dabur India is set to raise prices by up to 4 per cent across parts of its portfolio and reduce grammage in smaller packs as the company grapples with rising input costs triggered by the ongoing conflict in West Asia.Speaking to analysts after the company’s quarterly earnings announcement, Dabur Global Chief Executive Officer Mohit Malhotra said inflationary pressures have intensified across most categories of the India business, prompting the compa…